Elastic biopolymer and use as a tissue adhesive
The present invention provides an improved tissue adhesive to repair defects in soft tissue. Following ASTM standard tests, crosslinked methacryloyl-substituted gelatin hydrogels of the present invention (GelSEAL) were shown to exhibit adhesive properties, i.e. wound closure strength, shear resistance and burst pressure, that were superior to clinically used fibrin- and poly(ethylene glycol)-based glues. Chronic in vivo experiments in rats proved GelSEAL to effectively seal large lung leakages without additional sutures or staples, presenting improved performance as compared to fibrin and poly(ethylene glycol) glues. Furthermore, subcutaneous implantation in rats revealed high biocompatibility of GelSEAL as evidenced by low inflammatory host response. Advantageously, the tissue adhesives of the present invention are low cost and easy to produce, making them a promising substance to be used as a sealant for fluid leakages in soft tissue, as well as an easily tunable platform to further optimize the adhesive characteristics.
1. A tissue adhesive comprising a light activated methacryloyl-substituted gelatin, a photoinitiator, and a pharmaceutically acceptable carrier, wherein the methacryloyl-substituted gelatin is present at a concentration between 20% and 40% (w/v), and wherein the tissue adhesive has a burst pressure of at least 10 kPa when the methacryloyl-substituted gelatin is cross-linked by photo-irradiation.
2. The tissue adhesive of claim 1 , wherein the methacryloyl-substituted gelatin has a degree of methacryloyl substitution between 50% and 90%.
3. The tissue adhesive of claim 1 , wherein the methacryloyl-substituted gelatin is present at a concentration between 20% and 35% (w/v).
4. The tissue adhesive of claim 1 , wherein the photoinitiator is selected from the group consisting of: 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propane-1-one, azobisisobutyronitrile, benzoyl peroxide, di-tert-butyl peroxide, 2,2-dimethoxy-2-phenylacetophenone, Eosin Y, and any combination thereof.
5. The tissue adhesive of claim 1 , further comprising:
a hemostatic agent selected from the group consisting of blood coagulation factors, prothrombin, thrombin, silicate nanoparticles, and any combination thereof; or
(ii) an antibacterial agent selected from the group consisting of silver nanoparticles, copper oxide nanoparticles, nanoparticle-carried antibiotic drugs, penicillins, cephalosporins, penems, carbapenems, monobactams, aminoglycosides, sulfonamides, macrolides, tetracyclins, lincosides, quinolones, chloramphenicol, vancomycin, metronidazole, rifampin, isoniazid, spectinomycin, trimethoprim sulfamethoxazole, chitosan, and any combination thereof.
6. The tissue adhesive of claim 1 , wherein the methacryloyl-substituted gelatin further comprises dopamine conjugated to the gelatin.
7. The composition of claim 1 , wherein the methacryloyl-substituted gelatin is present at a concentration between 25% and 35% (w/v).
8. The composition of claim 1 , wherein the methacryloyl-substituted gelatin is present at a concentration of about 25% (w/v).
9. A method for adhering or sealing soft tissue, comprising the steps of:
a. Applying the tissue adhesive of claim 1 to the soft tissue to be adhered or sealed; and
b. Exposing the composition to UV or visible light for a time sufficient to cross-link the methacryloyl-substituted gelatin to produce a tissue adhesive that has a burst pressure of at least 10 kPa.
10. The method of claim 9 , wherein the soft tissue is a highly stressed elastic tissue.
11. The method of claim 9 , wherein the method provides a seal against leakage of a fluid through the soft tissue.
12. The method of claim 9 , wherein the composition is exposed to UV or visible light for a time period between 3 minutes and 5 minutes.
13. The method of claim 9 , wherein the method does not comprise suturing or stapling the soft tissue to be adhered or sealed.